论文部分内容阅读
以左旋多巴为主的替代疗法仍然在当今临床治疗帕金森病中扮演主要角色。近年来随着现代科技的发展和人们对帕金森病发病的病因和病理的再认识，以神经保护性治疗为主的一些新的治疗方案正日渐成熟并在逐步走向临床，而与此同时另一些新的治疗方案和药物正在不断被提出和研制。可以预期这些新疗法的实施将会为有效地缓解帕金森病病人的痛苦和延缓疾病的进展作出贡献。本文旨在对方面的研究作一介绍。
Levodopa-based alternative therapies still play a major role in today’s clinical treatment of Parkinson’s disease. In recent years, with the development of modern science and technology and people’s re-understanding of the etiology and pathology of Parkinson’s disease, some new treatment programs based on neuroprotective therapy are gradually becoming mature and gradually moving toward clinical practice. Meanwhile, A number of new treatment options and medicines are being proposed and developed. It is expected that the implementation of these new therapies will contribute to effectively alleviating the suffering and delaying the progression of the disease in patients with Parkinson’s disease. The purpose of this paper is to introduce the research in this area.